{"count": 34, "results": [{"_id": "37551050", "pmid": 37551050, "pmcid": "PMC10497034", "title": "Amlodipine in the current management of hypertension", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Wang JG", "Palmer BF", "Vogel Anderson K", "Sever P"], "date": "2023-08-07T00:00:00Z", "doi": "10.1111/jch.14709", "meta_date_publication": "2023 Aug 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50275.848, "text_hl": "Side effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ include @DISEASE_Edema @DISEASE_MESH:D004487 @@@edema@@@, @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@palpitations@@@, @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, and @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@, which are more common with the higher dose of 10 mg. ", "citations": {"NLM": "Wang JG, Palmer BF, Vogel Anderson K, Sever P. Amlodipine in the current management of hypertension J Clin Hypertens (Greenwich). 2023 Aug 7;():. PMID: 37551050", "BibTeX": "@article{37551050, title={Amlodipine in the current management of hypertension}, author={Wang JG and Palmer BF and Vogel Anderson K and Sever P}, journal={J Clin Hypertens (Greenwich)}}"}}, {"_id": "14758392", "pmid": 14758392, "title": "Amlodipine associated hyperpigmentation.", "journal": "Saudi Med J", "authors": ["Erbagci Z"], "date": "2004-01-01T00:00:00Z", "meta_date_publication": "2004 Jan", "meta_volume": "25", "meta_issue": "1", "meta_pages": "103-5", "score": 50082.996, "text_hl": "Although @DISEASE_Hyperpigmentation @DISEASE_MESH:D017495 @@@cutaneous hyperpigmentation@@@ was most prominent on the photoexposed areas, there was no history of previous photosensitivity, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@ or @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@. To our knowledge, no case of @DISEASE_Hyperpigmentation @DISEASE_MESH:D017495 @@@oral and cutaneous hyperpigmentation@@@ associated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ has been formally reported up to date.", "citations": {"NLM": "Erbagci Z. Amlodipine associated hyperpigmentation. Saudi Med J. 2004 Jan;25(1):103-5. PMID: 14758392", "BibTeX": "@article{14758392, title={Amlodipine associated hyperpigmentation.}, author={Erbagci Z}, journal={Saudi Med J}, volume={25}, number={1}, pages={103-5}}"}}, {"_id": "28387969", "pmid": 28387969, "title": "Amlodipine: The double edged sword.", "journal": "J Paediatr Child Health", "authors": ["Rabah F", "El-Naggari M", "Al-Nabhani D"], "date": "2017-06-01T00:00:00Z", "doi": "10.1111/jpc.13517", "meta_date_publication": "2017 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "540-542", "score": 50078.363, "text_hl": "This is mainly due to its long half-life making it easy to use as a single daily dose. @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ is associated with common side effects like @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@, @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@. ", "citations": {"NLM": "Rabah F, El-Naggari M, Al-Nabhani D. Amlodipine: The double edged sword. J Paediatr Child Health. 2017 Jun;53(6):540-542. PMID: 28387969", "BibTeX": "@article{28387969, title={Amlodipine: The double edged sword.}, author={Rabah F and El-Naggari M and Al-Nabhani D}, journal={J Paediatr Child Health}, volume={53}, number={6}, pages={540-542}}"}}, {"_id": "10437993", "pmid": 10437993, "title": "Amlodipine treatment of cocaine dependence.", "journal": "J Psychoactive Drugs", "authors": ["Malcolm R", "Brady KT", "Moore J", "Kajdasz D"], "date": "1999-04-01T00:00:00Z", "doi": "10.1080/02791072.1999.10471733", "meta_date_publication": "1999 Apr-Jun", "meta_volume": "31", "meta_issue": "2", "meta_pages": "117-20", "score": 50074.625, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ treatment of @DISEASE_Cocaine_Related_Disorders @DISEASE_MESH:D019970 @@@cocaine dependence@@@.", "citations": {"NLM": "Malcolm R, Brady KT, Moore J, Kajdasz D. Amlodipine treatment of cocaine dependence. J Psychoactive Drugs. 1999 Apr-Jun;31(2):117-20. PMID: 10437993", "BibTeX": "@article{10437993, title={Amlodipine treatment of cocaine dependence.}, author={Malcolm R and Brady KT and Moore J and Kajdasz D}, journal={J Psychoactive Drugs}, volume={31}, number={2}, pages={117-20}}"}}, {"_id": "16296714", "pmid": 16296714, "title": "An update on the safety of amlodipine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Osterloh IH"], "date": "1991-01-01T00:00:00Z", "doi": "10.1097/00005344-199117001-00020", "meta_date_publication": "1991", "meta_volume": "17 Suppl 1", "meta_issue": "", "meta_pages": "S65-8", "score": 50074.062, "text_hl": "Although @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ is a potent vasodilator, there was a low incidence of side effects such as @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@, and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@. ", "citations": {"NLM": "Osterloh IH. An update on the safety of amlodipine. J Cardiovasc Pharmacol. 1991;17 Suppl 1():S65-8. PMID: 16296714", "BibTeX": "@article{16296714, title={An update on the safety of amlodipine.}, author={Osterloh IH}, journal={J Cardiovasc Pharmacol}, volume={17 Suppl 1}, pages={S65-8}}"}}, {"_id": "10940749", "pmid": 10940749, "title": "Amlodipine besylate induced acute interstitial nephritis.", "journal": "Nephron", "authors": ["Ejaz AA", "Fitzpatrick PM", "Haley WE", "Wasiluk A", "Durkin AJ", "Zachariah PK"], "date": "2000-08-01T00:00:00Z", "doi": "10.1159/000045688", "meta_date_publication": "2000 Aug", "meta_volume": "85", "meta_issue": "4", "meta_pages": "354-6", "score": 50073.723, "text_hl": "...Adverse effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@, a widely used antihypertensive medication, include @DISEASE_Edema @DISEASE_MESH:D004487 @@@peripheral edema@@@, @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@, @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, and @DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@. ", "citations": {"NLM": "Ejaz AA, Fitzpatrick PM, Haley WE, Wasiluk A, Durkin AJ, Zachariah PK. Amlodipine besylate induced acute interstitial nephritis. Nephron. 2000 Aug;85(4):354-6. PMID: 10940749", "BibTeX": "@article{10940749, title={Amlodipine besylate induced acute interstitial nephritis.}, author={Ejaz AA and Fitzpatrick PM and Haley WE and Wasiluk A and Durkin AJ and Zachariah PK}, journal={Nephron}, volume={85}, number={4}, pages={354-6}}"}}, {"_id": "16296697", "pmid": 16296697, "title": "Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.", "journal": "J Cardiovasc Pharmacol", "authors": ["Abernethy DR"], "date": "1991-01-01T00:00:00Z", "meta_date_publication": "1991", "meta_volume": "17 Suppl 1", "meta_issue": "", "meta_pages": "S4-7", "score": 50071.79, "text_hl": "The pharmacokinetic properties of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ avoid the sharp fluctuations in plasma level seen with other calcium antagonists that are associated with vasodilatation-induced side effects such as @DISEASE_Tachycardia @DISEASE_MESH:D013610 @@@tachycardia@@@, @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, and @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@. ", "citations": {"NLM": "Abernethy DR. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist. J Cardiovasc Pharmacol. 1991;17 Suppl 1():S4-7. PMID: 16296697", "BibTeX": "@article{16296697, title={Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.}, author={Abernethy DR}, journal={J Cardiovasc Pharmacol}, volume={17 Suppl 1}, pages={S4-7}}"}}, {"_id": "24384734", "pmid": 24384734, "pmcid": "PMC3862199", "title": "Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension ", "journal": "Curr Ther Res Clin Exp", "authors": ["Na JO", "Seo HS", "Choi CU", "Lim HE", "Kim JW", "Kim EJ", "Han SW", "Rha SW", "Park CG", "Oh DJ", "ELDER investigators"], "date": "2013-06-01T00:00:00Z", "doi": "10.1016/j.curtheres.2013.02.001", "meta_date_publication": "2013 Jun", "meta_volume": "74", "meta_issue": "", "meta_pages": "54-61", "score": 50069.17, "text_hl": "The most common drug-related AEs were @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ (n = 3), @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@facial flushing@@@ (n = 2), and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@ (n = 2) in the @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@ group, and @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ (n = 6), @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@facial flushing@@@ (n = 5) in the @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ group. ", "citations": {"NLM": "Na JO, Seo HS, Choi CU, Lim HE, Kim JW, Kim EJ, Han SW, Rha SW, Park CG, Oh DJ, ELDER investigators. Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension  Curr Ther Res Clin Exp. 2013 Jun;74():54-61. PMID: 24384734", "BibTeX": "@article{24384734, title={Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension }, author={Na JO and Seo HS and Choi CU and Lim HE and Kim JW and Kim EJ and Han SW and Rha SW and Park CG and Oh DJ and ELDER investigators}, journal={Curr Ther Res Clin Exp}, volume={74}, pages={54-61}}"}}, {"_id": "11041159", "pmid": 11041159, "title": "Treatment of hypertensive children with amlodipine.", "journal": "Am J Hypertens", "authors": ["Flynn JT", "Smoyer WE", "Bunchman TE"], "date": "2000-10-01T00:00:00Z", "doi": "10.1016/s0895-7061(00)00278-8", "meta_date_publication": "2000 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "1061-6", "score": 50068.848, "text_hl": "Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ children with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@.", "citations": {"NLM": "Flynn JT, Smoyer WE, Bunchman TE. Treatment of hypertensive children with amlodipine. Am J Hypertens. 2000 Oct;13(10):1061-6. PMID: 11041159", "BibTeX": "@article{11041159, title={Treatment of hypertensive children with amlodipine.}, author={Flynn JT and Smoyer WE and Bunchman TE}, journal={Am J Hypertens}, volume={13}, number={10}, pages={1061-6}}"}}, {"_id": "9727842", "pmid": 9727842, "title": "Amlodipine once-daily in systemic hypertension.", "journal": "Eur J Pediatr", "authors": ["Pfammatter JP", "Clericetti-Affolter C", "Truttmann AC", "Busch K", "Laux-End R", "Bianchetti MG"], "date": "1998-08-01T00:00:00Z", "doi": "10.1007/s004310050897", "meta_date_publication": "1998 Aug", "meta_volume": "157", "meta_issue": "8", "meta_pages": "618-21", "score": 50068.56, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ was withdrawn in five @SPECIES_9606 @@@patients@@@ who experienced @DISEASE_Tang_Hsi_Ryu_syndrome @DISEASE_MESH:C536897 @@@oedema@@@ and @<m>DISEASE_Flushing</m> @DISEASE_MESH:D005483 @@@flushing@@@. ", "citations": {"NLM": "Pfammatter JP, Clericetti-Affolter C, Truttmann AC, Busch K, Laux-End R, Bianchetti MG. Amlodipine once-daily in systemic hypertension. Eur J Pediatr. 1998 Aug;157(8):618-21. PMID: 9727842", "BibTeX": "@article{9727842, title={Amlodipine once-daily in systemic hypertension.}, author={Pfammatter JP and Clericetti-Affolter C and Truttmann AC and Busch K and Laux-End R and Bianchetti MG}, journal={Eur J Pediatr}, volume={157}, number={8}, pages={618-21}}"}}]}